Researchers at the University of Missouri Regional Biocontainment Lab are warning clinicians not to be too quick in diagnosing patients presenting with influenza-like symptoms.
Researchers at the University of Missouri Regional Biocontainment Lab are warning clinicians not to be too quick in diagnosing patients presenting with influenza-like symptoms. It may be Q fever, which is almost identical in presentation and is on the rise worldwide.
Symptoms of Q fever, which include fever, severe headache, cough, body pain, and gastrointestinal symptoms, typically do not surface until 2 to 3 weeks after exposure. Although the disease is most commonly transmitted through the air, it can be acquired by drinking unpasteurized milk or through the bite of infected ticks.
Definitive diagnosis requires a blood test. Antibiotics provide effective treatment, but the disease can be difficult to cure, especially in people with compromised immune systems.
The US Food and Drug Administration has not approved the vaccine currently being used in other countries because it can cause a severe skin reaction in persons already carrying Q fever bacteria. Research on a vaccine with a better safety profile is under way.
For expert comment: 'Q fever' mimics the flu and can be missed by physicians. [news release.] Columbia, Missouri:University of Missouri News Bureau; November 3, 2010. http://munews.missouri.edu/expert-comment/2010/1103-for-expert-comment"q-fever"-mimics-the-flu-and-can-be-missed-by-physicians/. Accessed November 3, 2010.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More